- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lupin awarded EcoVadis Silver Medal for sustainability excellence

Mumbai: Global pharma major Lupin Limited has announced that it has been awarded "Silver Medal" by EcoVadis for its outstanding sustainability management practices in areas such as Environment, Labor and Human Rights, Ethics and Sustainable Procurement.
This prestigious achievement places Lupin amongst the top 15% of companies evaluated by EcoVadis.
EcoVadis is a globally trusted provider of business sustainability ratings with a network of more than 150,000 companies being rated. The EcoVadis sustainability assessment methodology evaluates the integration of sustainability principles effectively into a company’s business and management system.
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring, moving up from 51 in 2024 to 69 in 2025. With this achievement, Lupin is positioned at the 87th percentile in the 2025 assessment.
Commenting on the achievement, Ramesh Swaminathan, Executive Director, Global CFO and Head – API Plus SBU, Lupin said, “This milestone is a reaffirmation of our commitment to developing superior, cost-effective pharmaceutical products and enabling robust supply chain practices that prioritize environmental sustainability. We, along with our partners, are committed to ensuring that every product we manufacture propels us towards building a sustainable future and a healthier planet, while enhancing value for all our stakeholders.”
Read also: Lupin Launches Empagliflozin Linagliptin FDC, AjaDuo At Affordable Prices
Earlier this year, Lupin received an “A-” leadership rating from CDP for its outstanding performance in climate change and water security. Additionally, Lupin’s S&P Global ESG scores moved to 76 from 69 last year, above the industry average of 30 in the pharmaceuticals sector.
Read also: Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751